How many employees does Evolus, Inc. have?

Evolus, Inc. reported 334 employees for the fiscal year ending Dec 2025, in the annual report it filed on March 3, 2026. That is up 0.6% from a year earlier.

What is Evolus, Inc.'s revenue per employee?

Evolus, Inc. brought in $297M of revenue in fiscal Dec 2025, which is $890K per employee. That ranks 7 of 17 companies we track in Drug Manufacturers - Specialty & Generic, where the median is $825K.

Where do these numbers come from?

Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Company data

Evolus, Inc. employees and revenue per employee

EOLS · Drug Manufacturers - Specialty & Generic · $509M market cap

Evolus, Inc. had 334 employees at the end of fiscal Dec 2025, up 0.6% from a year earlier. Revenue for the year was $297M, up 11.6% from a year earlier, or $890K per employee. Revenue and headcount both grew, and revenue grew faster.

Employees

334

+0.6% YoY

Revenue

$297M

+11.6% YoY

Revenue / employee

$890K

Peer median $825K

Rank in industry

7 of 17

Drug Manufacturers - Specialty & Generic

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2019

Hover a year for the numbers.

EOLS employees and revenue by fiscal year
Year ending	Employees	Revenue	Per employee	Staff YoY	Revenue YoY
Dec 2025	334	$297M	$890K	+0.6%	+11.6%
Dec 2024	332	$266M	$802K	+21.6%	+31.8%
Dec 2023	273	$202M	$740K	+27.0%	+36.0%
Dec 2022	215	$149M	$691K	+28.7%	+49.1%
Dec 2021	167	$99.7M	$597K	+40.3%	+76.3%
Dec 2020	119	$56.5M	$475K	-49.4%	+61.9%
Dec 2019	235	$34.9M	$149K	—	—

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years

Revenue per employee, last six fiscal years

Evolus, Inc. against similar companies

The closest industry peers by revenue, from Drug Manufacturers - Specialty & Generic.

Company	Employees	Revenue	Revenue / employee	Shape
COLL Collegium Pharmaceutical, Inc.	423	$781M	$1.85M	Efficient growth
ETON Eton Pharmaceuticals, Inc.	44	$80.0M	$1.82M	Efficient growth
SUPN Supernus Pharmaceuticals, Inc.	778	$719M	$924K	Hiring ahead
ANIP ANI Pharmaceuticals, Inc.	970	$883M	$911K	Efficient growth
EOLS Evolus, Inc.	334	$297M	$890K	Efficient growth
PCRX Pacira BioSciences, Inc.	825	$726M	$880K	Hiring ahead
EBS Emergent BioSolutions Inc.	900	$743M	$825K	Contracting
HROW Harrow Health, Inc.	373	$272M	$730K	Leaner
AMPH Amphastar Pharmaceuticals, Inc.	1,976	$720M	$364K	Contracting

Every Healthcare company

Questions about Evolus, Inc.

How many employees does Evolus, Inc. have?: Evolus, Inc. reported 334 employees for the fiscal year ending Dec 2025, in the annual report it filed on March 3, 2026. That is up 0.6% from a year earlier.
What is Evolus, Inc.'s revenue per employee?: Evolus, Inc. brought in $297M of revenue in fiscal Dec 2025, which is $890K per employee. That ranks 7 of 17 companies we track in Drug Manufacturers - Specialty & Generic, where the median is $825K.
Where do these numbers come from?: Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Free game

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

More data

Compare EOLS with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Leaderboard Healthcare

Source: employee counts and revenue as stated in Evolus, Inc.'s annual reports (Form 10-K), latest filed March 3, 2026. This is data, not a recommendation to buy or sell EOLS.